L., Dahl, K., Schffer, L., Sensfuss, U., Poulsen, C., Schlein, M., Hansen, A
Semaglutide Component Properties Complete Specifications: Classification: GLP-1 receptor agonist Molecular Weight: 4,113 Da Molecular Formula: CHNO Structural Basis: Modified human GLP-1(7-37) with Aib8 and C18 fatty acid at K26 Key Modifications: Aminoisobutyric acid (Aib) at position 8, C18 fatty diacid at K26, linker modifications Primary Target: GLP-1 receptors (class B GPCR) Mechanism: GLP-1 receptor agonism with 94% albumin binding Plasma Half-Life: ~165 hours (~7 days), enabling once-weekly research administration CAS Number: 910463-68-2 Appearance: White to off-white lyophilized powder The semaglutide component provides long-acting GLP-1 receptor activation research capabilities
Their primary therapeutic actions include stimulating glucose-dependent insulin secretion, suppressing glucagon release, slowing gastric emptying to promote satiety, and acting on hypothalamic appetite centers to reduce hunger and caloric intake
How to Spot a Real GHK-Cu Product: Ensuring Quality and Authenticity To navigate the market effectively and avoid ineffective or potentially harmful counterfeits, use these checks to identify a reliable GHK-Cu product: Green Flags in Credible Documentation Color Check: Authentic GHK-Cu powder is typically blue to blue-purple due to the copper(II) ion
